Knight S - Search Results

1

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.

John T, Starmans MH, Chen YT, Russell PA, Barnett SA, White SC, Mitchell PL, Walkiewicz M, Azad A, Lambin P, Tsao MS, Deb S, Altorki N, Wright G, Knight S, Boutros PC, Cebon JS. John T, et al. Among authors: knight s. PLoS One. 2013 Jul 23;8(7):e67876. doi: 10.1371/journal.pone.0067876. Print 2013. PLoS One. 2013. PMID: 23935846 Free PMC article.

2

Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer.

Thomas DM, Mitchell PL, Berlangieri SU, Tochon-Danguy H, Knight S, Clarke CP, Scott AM. Thomas DM, et al. Among authors: knight s. Med J Aust. 1998 Aug 17;169(4):227. doi: 10.5694/j.1326-5377.1998.tb140229.x. Med J Aust. 1998. PMID: 9734584 No abstract available.

3

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.

Berlangieri SU, Scott AM, Knight SR, Fitt GJ, Hennessy OF, Tochon-Danguy HJ, Clarke CP, McKay WJ. Berlangieri SU, et al. Among authors: knight sr. Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S25-30. doi: 10.1016/s1010-7940(99)00179-7. Eur J Cardiothorac Surg. 1999. PMID: 10536941 Clinical Trial.

4

Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.

Yap KK, Yap KS, Byrne AJ, Berlangieri SU, Poon A, Mitchell P, Knight SR, Clarke PC, Harris A, Tauro A, Rowe CC, Scott AM. Yap KK, et al. Among authors: knight sr. Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1033-40. doi: 10.1007/s00259-005-1821-0. Epub 2005 May 5. Eur J Nucl Med Mol Imaging. 2005. PMID: 15875178

5

A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.

Scott AM, Lee FT, Jones R, Hopkins W, MacGregor D, Cebon JS, Hannah A, Chong G, U P, Papenfuss A, Rigopoulos A, Sturrock S, Murphy R, Wirth V, Murone C, Smyth FE, Knight S, Welt S, Ritter G, Richards E, Nice EC, Burgess AW, Old LJ. Scott AM, et al. Among authors: knight s. Clin Cancer Res. 2005 Jul 1;11(13):4810-7. doi: 10.1158/1078-0432.CCR-04-2329. Clin Cancer Res. 2005. PMID: 16000578 Clinical Trial.

6

Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.

Cherk MH, Foo SS, Poon AM, Knight SR, Murone C, Papenfuss AT, Sachinidis JI, Saunder TH, O'Keefe GJ, Scott AM. Cherk MH, et al. Among authors: knight sr. J Nucl Med. 2006 Dec;47(12):1921-6. J Nucl Med. 2006. PMID: 17138734 Free article.

7

Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.

Lee ST, Berlangieri SU, Poon AM, Mitchell P, Pathmaraj K, Tabone K, Byrne AJ, O'Keefe GJ, Knight SR, Clarke CP, Scott AM. Lee ST, et al. Among authors: knight sr. Intern Med J. 2007 Nov;37(11):753-9. doi: 10.1111/j.1445-5994.2007.01383.x. Epub 2007 May 21. Intern Med J. 2007. PMID: 17517082

8

Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma.

Lee ST, Ghanem M, Herbertson RA, Berlangieri SU, Byrne AJ, Tabone K, Mitchell P, Knight SR, Feigen M, Scott AM. Lee ST, et al. Among authors: knight sr. Mol Imaging Biol. 2009 Nov-Dec;11(6):473-9. doi: 10.1007/s11307-009-0203-6. Epub 2009 Mar 28. Mol Imaging Biol. 2009. PMID: 19330385

9

Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-(18)F-fluoro-2-deoxy-D-glucose positron emission tomogram mediastinal staging.

Barnett S, Baste JM, Murugappan K, Tog C, Berlangieri S, Scott A, Seevanayagam S, Knight S. Barnett S, et al. Among authors: knight s. Eur J Cardiothorac Surg. 2011 Jan;39(1):96-101. doi: 10.1016/j.ejcts.2010.04.040. Epub 2010 Jul 1. Eur J Cardiothorac Surg. 2011. PMID: 20580245

10

KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer.

Tie J, Lipton L, Desai J, Gibbs P, Jorissen RN, Christie M, Drummond KJ, Thomson BN, Usatoff V, Evans PM, Pick AW, Knight S, Carne PW, Berry R, Polglase A, McMurrick P, Zhao Q, Busam D, Strausberg RL, Domingo E, Tomlinson IP, Midgley R, Kerr D, Sieber OM. Tie J, et al. Among authors: knight s. Clin Cancer Res. 2011 Mar 1;17(5):1122-30. doi: 10.1158/1078-0432.CCR-10-1720. Epub 2011 Jan 14. Clin Cancer Res. 2011. PMID: 21239505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,940 results

Search Page

Filters